Study of RC18 Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus(SLE)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02885610 |
|
Recruitment Status :
Completed
First Posted : August 31, 2016
Last Update Posted : March 4, 2020
|
Sponsor:
RemeGen Co., Ltd.
Information provided by (Responsible Party):
RemeGen Co., Ltd.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | June 11, 2019 |
| Actual Study Completion Date : | July 9, 2019 |